According to Liu and colleagues, ASCT2 expression levels can modulate the migration capacity of CRC cells, being the overexpression of this AA transportersassociated with a poorer patients’ prognosis [1,27]. The gene discussed is SLC1A5; the disease is colorectal carcinoma.